constant pressure perfusion langendorff system Search Results


90
Harvard Bioscience constant pressure perfusion langendorff system
We characterize calcium transients in ventricular cardiomyocytes in response to drugs, both computationally (top) and experimentally (bottom) and identify the ion channels that most likely generate early afterdepolarizations (left). We then screen the concentration space of the two most relevant channels and identify the classification boundary between the arrhythmic and non-arrhythmic domains using high performance computing and machine learning (center). We validate our approach using electrocardiograms, both computationally and experimentally, in whole heart simulations and isolated <t>Langendorff</t> perfused hearts (right). We demonstrate the potential of our new classifier by risk stratifying 23 common drugs and comparing the result against the reported risk categories of these compounds.
Constant Pressure Perfusion Langendorff System, supplied by Harvard Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/bio_rxiv__545863-158-24-29?v=Harvard+Bioscience
Average 90 stars, based on 1 article reviews
constant pressure perfusion langendorff system - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Radnoti LLC langendorff constant pressure apparatus
We characterize calcium transients in ventricular cardiomyocytes in response to drugs, both computationally (top) and experimentally (bottom) and identify the ion channels that most likely generate early afterdepolarizations (left). We then screen the concentration space of the two most relevant channels and identify the classification boundary between the arrhythmic and non-arrhythmic domains using high performance computing and machine learning (center). We validate our approach using electrocardiograms, both computationally and experimentally, in whole heart simulations and isolated <t>Langendorff</t> perfused hearts (right). We demonstrate the potential of our new classifier by risk stratifying 23 common drugs and comparing the result against the reported risk categories of these compounds.
Langendorff Constant Pressure Apparatus, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc10145941-175-10-9?v=Radnoti+LLC
Average 90 stars, based on 1 article reviews
langendorff constant pressure apparatus - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
ADInstruments mouse langendorff apparatus
We characterize calcium transients in ventricular cardiomyocytes in response to drugs, both computationally (top) and experimentally (bottom) and identify the ion channels that most likely generate early afterdepolarizations (left). We then screen the concentration space of the two most relevant channels and identify the classification boundary between the arrhythmic and non-arrhythmic domains using high performance computing and machine learning (center). We validate our approach using electrocardiograms, both computationally and experimentally, in whole heart simulations and isolated <t>Langendorff</t> perfused hearts (right). We demonstrate the potential of our new classifier by risk stratifying 23 common drugs and comparing the result against the reported risk categories of these compounds.
Mouse Langendorff Apparatus, supplied by ADInstruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc10068866-444-8-11?v=ADInstruments
Average 93 stars, based on 1 article reviews
mouse langendorff apparatus - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Radnoti LLC langendorff constant pressure non-recirculating system
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Langendorff Constant Pressure Non Recirculating System, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc03630723-21-20-25?v=Radnoti+LLC
Average 90 stars, based on 1 article reviews
langendorff constant pressure non-recirculating system - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
ADInstruments constant perfusion pressure apparatus
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Constant Perfusion Pressure Apparatus, supplied by ADInstruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/bio_rxiv__2025__02__24__639999-88-2-6?v=ADInstruments
Average 93 stars, based on 1 article reviews
constant perfusion pressure apparatus - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Gilson Inc minipulse 3 peristaltic pump
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Minipulse 3 Peristaltic Pump, supplied by Gilson Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc02718260-95-14-17?v=Gilson+Inc
Average 90 stars, based on 1 article reviews
minipulse 3 peristaltic pump - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

93
ADInstruments adult mouse hearts
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Adult Mouse Hearts, supplied by ADInstruments, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc01592290-163-5-15?v=ADInstruments
Average 93 stars, based on 1 article reviews
adult mouse hearts - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier

90
Merieux NutriSciences sodium pentobarbitone
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Sodium Pentobarbitone, supplied by Merieux NutriSciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc03313659-44-33-21?v=Merieux+NutriSciences
Average 90 stars, based on 1 article reviews
sodium pentobarbitone - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Radnoti LLC gravity fed, constant-pressure langendorff perfusion system
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Gravity Fed, Constant Pressure Langendorff Perfusion System, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc11076594-283-19-23?v=Radnoti+LLC
Average 90 stars, based on 1 article reviews
gravity fed, constant-pressure langendorff perfusion system - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Radnoti LLC langendorff system
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Langendorff System, supplied by Radnoti LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pmc04802457-53-38-40?v=Radnoti+LLC
Average 90 stars, based on 1 article reviews
langendorff system - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Verlag GmbH isolated perfused warm-blooded heart according to langendorff
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Isolated Perfused Warm Blooded Heart According To Langendorff, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/us09974814-83-11-23?v=Verlag+GmbH
Average 90 stars, based on 1 article reviews
isolated perfused warm-blooded heart according to langendorff - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Biochrom collagenase cls ii
Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, <t>Langendorff-perfused</t> rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.
Collagenase Cls Ii, supplied by Biochrom, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/constant+pressure+perfusion+langendorff+system/pm31504244-52-34-47?v=Biochrom
Average 90 stars, based on 1 article reviews
collagenase cls ii - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


We characterize calcium transients in ventricular cardiomyocytes in response to drugs, both computationally (top) and experimentally (bottom) and identify the ion channels that most likely generate early afterdepolarizations (left). We then screen the concentration space of the two most relevant channels and identify the classification boundary between the arrhythmic and non-arrhythmic domains using high performance computing and machine learning (center). We validate our approach using electrocardiograms, both computationally and experimentally, in whole heart simulations and isolated Langendorff perfused hearts (right). We demonstrate the potential of our new classifier by risk stratifying 23 common drugs and comparing the result against the reported risk categories of these compounds.

Journal: bioRxiv

Article Title: Classifying drugs by their arrhythmogenic risk using machine learning

doi: 10.1101/545863

Figure Lengend Snippet: We characterize calcium transients in ventricular cardiomyocytes in response to drugs, both computationally (top) and experimentally (bottom) and identify the ion channels that most likely generate early afterdepolarizations (left). We then screen the concentration space of the two most relevant channels and identify the classification boundary between the arrhythmic and non-arrhythmic domains using high performance computing and machine learning (center). We validate our approach using electrocardiograms, both computationally and experimentally, in whole heart simulations and isolated Langendorff perfused hearts (right). We demonstrate the potential of our new classifier by risk stratifying 23 common drugs and comparing the result against the reported risk categories of these compounds.

Article Snippet: We excised the hearts from anesthetized rats (2.5% isoflurane in 95% oxygen and 5% carbon dioxide), immediately cannulated the aorta, connected it to a constant pressure perfusion Langendorff system (Harvard Apparatus, Massachusetts) with Krebs solution (118mM NaCl, 4.75mM KCl, 25mM NaHCO 3 , 1.2mM KH 2 PO 4 , 1.2mM MgSO 4 , 1.5mM CaCl 2 , 11mM glucose, and 2mM Pyruvate), warmed to 37° C, and bubbled with 95% oxygen and 5% carbon dioxide.

Techniques: Concentration Assay, Isolation

Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, Langendorff-perfused rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.

Journal: Indian Journal of Pharmaceutical Sciences

Article Title: Mechanism(s) Involved in Carbon Monoxide-releasing Molecule-2-mediated Cardioprotection During Ischaemia-reperfusion Injury in Isolated Rat Heart

doi: 10.4103/0250-474X.107047

Figure Lengend Snippet: Experimental design for CORM-2-mediated cardioprotection and role of various kinases. The isolated, Langendorff-perfused rat hearts were stabilised for 10 min, perfused for 15 min with K–H buffer. Hearts were treated with Vehicle or iCORM-2 (inactive form of CORM) or CORM-2 (50 μM) (a, b and c). The treatment with various inhibitors like SCIO-469 (1 μM) or SB-203580 (10 μM) or chelerythrine (10 μM) or wortmannin (100 nM) was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment followed by 30 min of global ischaemia and 120 min of reperfusion (d, e and f). Some hearts (g, h and i) pretreated with CORM-2 and 100 nM wortmannin, the treatment with wortmannin was initiated 5 min before CORM-2 administration and continued during CORM-2 treatment and throughout reperfusion.

Article Snippet: Isolated heart was cannulated via aorta and perfused in the Langendorff's mode at constant perfusion pressure 70 mmHg using Radnoti Langendorff constant pressure non-recirculating system (Radnoti glass technology Inc., CA, USA).

Techniques: Isolation